Bioresorbable Scaffolds (eBook, PDF)

From Basic Concept to Clinical Applications
Redaktion: Onuma, Yoshinobu; Serruys, Patrick W. J. C.

• Format: PDF

Produktbeschreibung

This book focuses on the coronary bioresorbable scaffold, a new interventional treatment for coronary artery disease, differentiated from a permanent metallic stent. The book provides an overview of the technology including non-clinical studies and clinical evidences in order to help clinicians understand the appropriate application of the technology and the optimal techniques of implantation. It covers the basics of bioresorbable scaffolds; bench test results; preclinical studies; clinical evidences; and tips and tricks of implantation.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 549
• Erscheinungstermin: 2. Oktober 2017
• Englisch
• ISBN-13: 9781498779777
• Artikelnr.: 49378282

Autorenporträt

Prof. Patrick W. Serruys is a professor of Interventional Cardiology at the Interuniversity Cardiological Institute of the Netherlands (1988-1998), and Erasmus MC. Since 1980 he was a Director of the Clinical Research Program of the Catheterization Laboratory, Thorax Center at Erasmus University, and till April 1st 2014 (retirement date) the Head of the Interventional Department, Thorax Center, Erasmus MC (University Medical Center Rotterdam), Rotterdam, The Netherlands. He is a Fellow of the American College of Cardiology and a Fellow of the European Society of Cardiology and scientific council of the International College of Angiology. In 1996 he received the TCT Career Achievement Award and in 1997 he was awarded the Wenkebach Prize of the Dutch Heart Foundation. In 2000 he was awarded the Gruentzig Award of the European Society of Cardiology. In 2001 he held the Paul Dudley White Lecture at the American Heart Association in the USA. In 2004 he received the Andreas Gruentzig Award of the Swiss Society of Cardiology. In 2005 he held the 4th International Lecture at the AHA and Mikamo Lecture at the Japanese heart Association. In 2006 he received the highest award of the Clinical Council of the American Heart Association: the James Herrick Award. In 2007 he received the Arrigo Recordati International Prize (Italy) and the ICI Achievement Award (bestowed by the President of Israel - Shimon Perez). In 2008 he received the Einthoven Penning (Leiden). In 2009 he became Doctor Honoris Causa from the University of Athens. In 2011 he received the Lifetime Achievement Award, bestowed by the American College of Cardiology, in recognition of many years of service and invaluable contributions to the ACC. At the end of 2011 Prof. Serruys received the Ray C. Fish Award, bestowed by the Texas Heart Institute, for outstanding achievement and contribution to cardiovascular medicine. In 2012 he received a Golden Medal of the European Society of Cardiology. In 2013 he became Doctor Honoris Causa from the Complutense University of Madrid.

Inhaltsangabe

Table of Contents
Section 1: Introduction
1.1- Early development of bioresorbable scaffold
Patrick W. Serruys
Section 2: Principles of bioresorption, vascular application
2.1- Degradable, biodegradable and bioresorbable polymers for time-limited
therapy
Michel Vert
2.2- Lactic acid-based polymers in depth
Michel Vert and Antoine Lafont
2.3- Scaffold processing
Jack Scanlon
2.4- Basics of biodegradation of magnesium
Michael Haude, Daniel Lootz, Hubertus Degen and Matthias Epple
2.5- Basics of biodegradation of iron scaffold
Deyuan Zhang and Runlin Gao
Section 3: From bench test to preclinical assessment
3.1- Unlocking scaffold mechanical properties
Jack Scanlon, Yoshinobu Onuma, Patrick W. Serruys and Joseph Deitzel
3.2- Bench testing for polymeric bioresorbable scaffolds
John A. Ormiston, Bruce Webber, Janarthanan Sathananthan, Pau
Medran-Gracia, Susann Beier and Mark WI Webster
3.3- Bench test for magnesium scaffold
Daniel Lootz, Wolfram Schmidt, Peter Behrens, Klaus-Peter Schmitz, Michael
Haude and Ron Waksman
3.4- Simulation of flow and shear stress
Nicolas Foin, Ryo Torii, Renick Darren Lee, Alessio Mattesini, Carlo Di
Mario, Philip Wong, Erhan Tenekecioglu, Tom Crake, Christos Bourantas and
Patrick W. Serruys
3.5- Preclinical assessment of bioresorbable scaffolds and regulatory
implication
Tobias Koppara, Eric Wittchow, Renu Virmani and Michael Joner
Section 4: Lesson learned from preclinical assessment
4.1- PLA scaffold
Kazuyuki Yahagi, Sho Torii, Erica Pacheco, Frank D. Kolodgie, Aloke V. Finn
and Renu Virmani
4.2- Iron
Runlin Gao, Deyuan Zhang, Hong Qiu, Chao Wu, Ying Xia and Gui Zhang
Section 5: Imaging to evaluate the bioresorbable scaffold: A corelab
perspective, methodology of measurement and assessment
5.1- Quantative coronary angiography of bioresorbable vascular scaffold: a
corelab perspective
Yohei Sotomi, Patrick W. Serruys and Yoshinobu Onuma
5.2- Assessment of bioresorbable scaffolds by IVUS: echogenicity, virtual
histology and palpography
Carlos M. Campos, Patrick W. Serruys and Hector M. Garcia-Garcia
5.3- Optical coherence tomography analysis vascular scaffold in comparison
with metallic stents: a corelab perspective
Yohei Sotomi, Pannipa Suwannasom, Jouke Dijkstra, Carlos Collet, Shimpei
Nakatani, Patrick W. Serruys, Yoshinobu Onuma
5.4- Non-invasive coronary tomography analysis after bioresorbable scaffold
implantation
Carlos Collet, Koen Nieman, Patrick W. Serruys and Yoshinobu Onuma
5.5- Angiography is sufficient
J Ribamar Costa, Jr. and Alexandre Abizaid
5.6- Intravascular ultrasound is a must in bioresorbable scaffold
implantation
Hiroyoshi Kawamoto, Neil Ruparelia and Antonio Colombo
5.7- OCT is the way to go
Jiang Ming Fam, Nienke Simone van Ditzhuijzen, Jors van Sjide, Bu Chan
Zhang, Antonios Karanasos, Robert-Jan van Geuns and Evelyn Regar
5.8- Imaging to evaluate the bioresorbable scaffold. Clinician's
perspective: I need both (IVUS and OCT)
Josep Gomez-Lara and Antoni Serra
5.9- Multislice computed tomography as a modality of follow-up
Antonio L. Bartorelli, Daniele Andreini, Simona Espejo and Manuel Pan
Section 6: Clinical evidence of randomised and non-randomised trials:
personal perspective
6.1- What are appropriate clinical endpoints? From device failure
assessment to angina evaluation
Maik J. Grundeken, Yoshinobu Onuma and Patrick W. Serruys
6.2- Angina reduction after BRS implantation: correlation with changes in
coronary haemodynamics
Nick E.J. West, Adam J. Brown and Stephen P. Hoole
6.3- Comparison of everolimus eluting bioresorbable scaffolds with
everolimus eluting metallic stents for treatment of coronary artery
stenosis: Three-year follow-up of the Absorb II randomized trial
Carlos Collet et al.
6.4- The ABSORB China trial
Runlin Gao
6.5- ABSORB Japan
Takeshi Kimura
6.6- What have we learned from meta-analysis of 1 year outcomes with the
Absorb bioresorbable scaffold in patients with coronary heart disease
Yohei Sotomi, Carlos Collet, Takeshi Kimura, Runlin Gao, Dean J. Kereiakes,
Gregg W. Stone, Stephen G. Ellis, Yoshinobu Onuma and Patrick W. Serruys
6.7- Summary of investigator-driven registries on absorb bioresorbable
vascular scaffolds
Anna Franzone, Raffaele Piccolo and Stephen Windecker
6.8- Investigator-driven randomised trials
Daniele Giacoppo, Roisin Colleran and Adnan Kastrati
6.9- The DESolve scaffold
Stefan Verheye, Nagarajan Ramesh, Lynn Morrison and Sara Toyloy
6.10- Results of clinical trials with BIOTRONIK magnesium scaffolds
Michael Haude, Daniel Lootz, Raimund Erbel, Jacques Koolen and Ron Waksman
6.11- The REVA medical program: from ReZolve® to Fantom®
Alexandre Abizaid and J. Ribamar Costa Jr.
6.12- The Amaranth's bioresorbable vascular scaffold technology
Alaide Chieffo, Juan F. Granada and Antonio Colombo
6.13- The mirage microfiber sirolimus eluting coronary scaffold
Teguh Santoso, Liew Houng Bang, Ricardo Costa, Daniel Chamié, Solomon Su,
Alexandre Abizaid, Yoshinobu Onuma and Patrick W. Serruys
6.14- The Igaki-Tamai stent: the legacy of the work of Hideo Tamai
Soji Nishio, Kunihiko Kosuga, Eisho Kyo, Takafumi Tsuji, Masaharu Okada,
Shinsaku Takeda, Yasutaka Inuzuka, Tatsuhiko Hata, Yuzo Takeuchi, Junya
Seki and Shigeru Ikeguchi
Section 7: Clinical evidence in specific patient subsets: personal
perspective
7.1- Left main interventions with BRS
Bert Everaert, Piera Capranzano, Corrado Tamburino, Ashok Seth and
Robert-Jan van Geuns
7.2- Bioresorbable scaffolds in bifurcations
Filippo Fingini, Hiroyoshi Kawamoto and Azeem Latib
7.3- BVS in chronic total occlusions: clinical evidence, tips and tricks
Antonio Serra
7.4- Bioresorbable scaffolds in diffuse disease
Neil Ruparelia, Hiroyoshi Kawamoto and Antonio Colombo
7.5- Bioresorbable scaffolds in mulitvessel coronary disease
R.P. Kraak, Maik J. Grundeken and J.J Wykrzykowska
7.6- Bioresorbable coronary scaffolds in non-St elevation acute coronary
syndromes
Charis Mamilou and Tommaso Gori
7.7- Bioresorbable vascular scaffold in ST-segment elevation myocardial
infarction: clinical evidence, tips and tricks
Giuseppe Giacchi and Manel Sabaté
7.8- Bioresorbable scaffolds for treating coronary artery disease in
patients with diabetes mellitus
Ayyaz Sultan, Takeshi Muramatsu and Javaid Iqbal
7.9- BRS in calcified lesions
Ashok Seth
7.10- BRS textbook: invasive sealing of vulnerable, high-risk lesions
Christos Bourantas, Ryo Torri, Nicolas Foin, Ajay Suri, Erhan Tenekecioglu,
Vikas Thondapu, Tom Crake, Peter Barlis and Patrick W. Serruys
Section 8: Complications (incidence, diagnosis, potential mechanisms and
treatment)
8.1- Acute and subacute scaffold thrombosis
Davide Capodanno
8.2- Late and very late scaffold thrombosis
Antonios Karanasos, Bu-Chun Zhang, Jors van der Sijde, Jiang-Ming Fam,
Robert-Jan van Geuns and Evelyn Regar
8.3- Treatment of bioresorbable scaffold failure
Cordula M. Felix, Bert Everaert, Nigel Jepson, Corrado Tamburino and
Robert-Jan van Geuns
8.4- Recoil and bioresorbable scaffolds
John A. Ormiston, Bruce Webber, Janarthanan Sathananthan and Mark WI
Webster
8.5- Scaffold disruption and late discontinuities
Yoshinobu Onuma, Patrick W. Serruys
8.6- The incidence, potential mechanism of side-branch occlusion after
implantation of bioresorbable scaffold(s): insights from ABSORB II
Yuki Ishibashi, Takeshi Muramatsu, Yohei Sotomi, Yoshinobu Onuma and
Patrick W. Serruys
Section 9: Tips and tricks to implant BRS
9.1- Tips and tricks for implanting BRS: sizing, pre- and post-dilatation
Akihito Tanaka, Richard J. Jabbour and Antonio Colombo
9.2- Approach to bifurcation lesions
Ashok Seth
Section 10: Emerging technologies (pre-CE mark, pre-FA, pre-PMDA and
pre-CFDA)
10.1- Overview of the field
Yoshinobu Onuma
10.2- MeRes100(TM)- a sirolimus eluting bioresorbable vascular scaffold
system
Ashok Seth, Babu Ezhumalai, Sanjeev Bhatt and Pratik Vasani
10.3- XINSORB bioresorbable vascular scaffold
Junbo Ge and Li Shen
10.4- NeoVas(TM) bioresorbable coronary scaffold system
Han Yangling
10.5- ArterioSorb(TM) bioresorbable scaffold by Arterius Ltd
Rasha Al-Lamee
10.6- Lifetech
Deyuan Zhang, Wenjiao Lin, Haiping Oi
10.7- Abbott: new generation absorb scaffold
Laura E. Leigh Perkins, Byron J. Lambert and Richard J. Rapoza